EBOS Group Limited releases its annual meeting presentations, detailing the company’s strategic updates and financial performance. The Chairman’s Address highlights key operational achievements and future directions for the business. Shareholders review the latest developments during the annual general meeting.
EBOS Group Limited (ASX:EBO) outlines its operational activities and recent business developments. The company provides insights into its performance and strategic initiatives in its latest updates.
EBOS Group reports a **9.9% year-over-year revenue increase** for fiscal year 2026, driven by its healthcare and medical technology segments. Despite growth in sales, the company’s **underlying net profit after tax (NPAT) declines by 3.1%** due to higher operational costs and margin pressures. The results reflect ongoing challenges in balancing revenue expansion with profitability.
EBOS Group Ltd reports **$13.5 billion in revenue** for FY26, a **9.9% increase** from the prior year. The company’s net profit rises **4.7% to $225.2 million**, marking steady financial growth. The dividend remains unchanged despite the profit improvement.
